YPrime ads

Built for Speed, Flexibility, and Certainty. That's more than a tagline. It's the standard sponsors increasingly expect from their eCOA partner. From accelerating study startup and supporting protocol amendments to enabling global studies across hundreds of languages, eCOA plays a critical role in trial execution. We're proud that this focus contributed to YPrime being recognized as a Leader in Everest Group eCOA PEAK Matrix® Assessment, the acknowledgements we've seen from Clinical Trials Arena, EcoVadis, and more. See how YPrime helps sponsors solve clinical trial challenges with certainty. https://lnkd.in/eUtjCg9E

Are you currently evaluating an IRT solution? Our IRT team put the questions you need to ask in our new Playbook. https://hubs.ly/Q04z_Bgj0 Rick Lavallee Jon Paras Carly Newhardt

Introducing The Biotech Sponsor's Playbook for IRT Success, a new guide for teams navigating IRT design, clinical supply management, and vendor selection. Most biotech companies implement IRT/RTSM only a handful of times across their organization's lifecycle, and the early decisions carry significant weight. Written by YPrime IRT experts, this playbook covers the questions to ask before committing to a system, and what to look for in the team behind it. Access the Playbook here - https://lnkd.in/gdK5nRQS/?utm_campaign=BB-Awareness-WC&utm_source=linkedin&utm_medium=paid&utm_id=707024663&hsa_acc=509312755&hsa_cam=707024663&hsa_grp=376845374&hsa_ad=1606015784&hsa_net=linkedin&hsa_ver=3 #IRT #RTSM #YPrime

YPrime’s new GLP-1 Playbook breaks down key strategies and common pitfalls to help clinical trial leaders accelerate drug development. Get the inside track now.

What if defining study logic was as simple as describing it? Today, we’re introducing YPrime’s AI-powered eCOA Calculation Engine. This new capability enables study teams to define calculation logic using natural language—reducing manual programming and accelerating study build timelines, while improving consistency and accuracy. Our approach to AI is deliberate. Every capability is designed to meet the quality, traceability, and reliability standards clinical trials demand. This is a practical step forward in simplifying study configuration and strengthening execution from the start. Read the full press release: https://hubs.ly/Q04dLLhp0 Michael Hughes Aubrey (Llanes) Verna #ClinicalTrials #eCOA #AI #ClinicalResearch #LifeSciences #DigitalHealth

Participant engagement isn’t just about reminders. It’s about reducing confusion. When participants clearly understand what’s expected, adherence improves, and endpoint risk drops. That’s why we’ve embedded engagement directly into the eCOA workflow with the new YPrime Participant Hub. https://hubs.ly/Q04g4Fl00